St. George’s Hospital, London

With nearly 8,000 dedicated staff caring for patients around the clock, we are the largest healthcare provider in southwest London.

Our main site, St. George’s Hospital in Tooting – one of the country’s principal teaching hospitals – is shared with St. George’s, University of London, which trains medical students and carries out advanced medical research. St. George’s Hospital also hosts the St. George’s, University of London and Kingston University Faculty of Health and Social Care Sciences, which is responsible for training a wide range of healthcare professionals from across the region.

As well as acute hospital services, we provide a wide variety of specialist care and a full range of community services to patients of all ages following integration with Community Services Wandsworth in 2010.

St. George’s Healthcare serves a population of 1.3 million across southwest London. A large number of services, such as cardiothoracic medicine and surgery, neurosciences and renal transplantation, also cover significant populations from Surrey and Sussex, totaling around 3.5 million people.

The trust also provides care for patients from a larger catchment area in southeast England, for specialties such as complex pelvic trauma. Other services treat patients from all over the country, such as family HIV care and bone narrow transplantation for non-cancer diseases. The trust also provides a nationwide state-of-the-art endoscopy training center.

A number of our services are members of established clinical networks which bring together doctors, nurses and other clinicians from a range of healthcare providers working to improve the quality of services for patients. These include the South London Cardiac and Stroke Network and the South West London and Surrey Trauma Network, for which St. George’s Hospital is the designated heart attack canter, hyper-acute stroke unit and major trauma center.

› St. Geoge’s Hospital site

Role in the project

St. George’s Hospital will be involved in the measurement, analysis and evaluation of the product focusing on the analytical performance evaluation. 

Key personnel assigned to the project

Professor Paul Collinson
Clinical interests: Professor Collinson is a consultant chemical pathologist at St George’s Healthcare and Professor of Cardiovascular Biomarkers. His main clinical interests are in hyperlipidaemia, the primary and secondary prevention of cardiac disease and complex lipid disorders and the use of cardiovascular biomarkers for the diagnosis and treatment of heart disease.

Professional profile: Dr Collinson graduated from St Catherine’s College, Cambridge in 1981 and trained at St Thomas’ Hospital, London. He was awarded his MD from Cambridge University in 1994. He is a fellow of the National Academy of Clinical Biochemists, The Royal College of Physicians of Edinburgh and the European Society of Cardiology. He is an expert advisor to the National Institute for Health and Clinical Excellence (NICE) on cardiac biomarkers, and is responsible for developing and introducing troponin and B-type natriuretic to the UK. He is the winner of the Hytest award for his lifetime achievements in cardiovascular diagnostics.

Dr. David Gaze (Study monitor)
Dr. Gaze is currently Cardiac Research Scientist within the Department of Chemical Pathology, Clinical Blood Sciences at St George’s Hospital and Medical School, London. In addition he is visiting lecturer in Sports Medicine at the University of Brunel and Visiting Professor of Cardiac Biochemistry at Nanjing University of Technology, China. He has over 15 years of experience in analytical and clinical evaluation of cardiac biomarkers. His interests are in the development and clinical utility of novel cardiac markers for the detection of cardiovascular disease with a special interest in the cardio renal and acute coronary syndrome populations. He has authored and co-authored in excess of 140 peer reviewed papers and 150 abstracts, as well as presented at over 40 internationally invited conferences. He has contributed five book chapters to cardiovascular related text books as well as writing a textbook on cardiac troponin. Currently he is writing a Clinical Blood Sciences textbook due to be published early 2015. He is a peer reviewer of 25 medical journals. He is a member of the Royal Society of Medicine of London; The Association for Clinical Biochemistry, of which he chairs the Clinical Sciences Review Committee for the Annals of Clinical Biochemistry. He is also a member of the American Association of Clinical Chemistry; Institute of Biomedical Sciences; Institute of Biology; European Society of Pathology; The Pathological Society of Great Britain and Ireland and associate member of the Royal Institution of London.